Literature DB >> 26768838

Impact of Renal Replacement Therapy in Childhood on Long-Term Socioprofessional Outcomes: A 30-year Follow-Up Study.

Lidwien A Tjaden1, Heleen Maurice-Stam2, Martha A Grootenhuis2, Kitty J Jager3, Jaap W Groothoff4.   

Abstract

OBJECTIVE: To evaluate socioprofessional outcomes after 30 years of renal replacement therapy (RRT) and explore predictors of these outcomes. STUDY
DESIGN: The cohort comprised all Dutch patients, born before 1979, who started RRT at age <15 years in 1972-1992. Outcomes including family life, educational attainment, and professional life were obtained in 2000 and 2010 in 80 out of 152 survivors. Participants also completed the Course of Life Questionnaire in 2000, which retrospectively assessed the achievement of developmental milestones while growing up. Socioprofessional outcomes in 2010 were compared with the age-matched general population and with outcomes obtained in 2000. Logistic regression analysis was performed to identify determinants of socioprofessional outcomes.
RESULTS: Mean age and time on RRT in 2010 were 40.6 years (range 32.1-52.4) and 28.9 years (range 18.1-39.7), respectively. Patients were less likely to be employed (62.5% vs 81.0%) and have children (28.8% vs 64.8%) compared with the age-matched general population. Comorbidities, dialysis, short stature, and fewer milestones on autonomy were associated with adverse outcomes. Compared with 2000, in 2010 more patients lived with a partner (68.8% vs 43.0%), and more patients had completed a high level educational degree (22.5% vs 13.9%). However, more patients were unable to work on medical grounds in 2010 (36.3% vs 16.3%).
CONCLUSIONS: Survivors of pediatric end-stage renal disease may gain social autonomy and optimal educational attainment at an older age compared with their general population counterparts. Awareness among health care professionals of the potential of these children and tailored psychosocial interventions might improve socioprofessional development.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 26768838     DOI: 10.1016/j.jpeds.2015.12.017

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  6 in total

1.  Eplet mismatch analysis and allograft outcome across racially diverse groups in a pediatric transplant cohort: a single-center analysis.

Authors:  Mary Carmelle Philogene; Anita Amin; Sheng Zhou; Olga Charnaya; Renato Vega; Niraj Desai; Alicia M Neu; Cozumel S Pruette
Journal:  Pediatr Nephrol       Date:  2019-10-10       Impact factor: 3.714

2.  Professional functioning of young adults with congenital coagulation disorders in the Netherlands.

Authors:  Perrine F Limperg; Heleen Maurice-Stam; Lotte Haverman; Michiel Coppens; Marieke J H A Kruip; Jeroen Eikenboom; Martha A Grootenhuis; Marjolein Peters
Journal:  Haemophilia       Date:  2019-03-12       Impact factor: 4.287

3.  Structural brain abnormalities in children and young adults with severe chronic kidney disease.

Authors:  Sophie Lijdsman; Marsh Königs; Marit S van Sandwijk; Antonia H Bouts; Koen van Hoeck; Huib de Jong; Marc Engelen; Jaap Oosterlaan; Frederike J Bemelman; Kim J Oostrom; Jaap W Groothoff
Journal:  Pediatr Nephrol       Date:  2021-11-20       Impact factor: 3.651

4.  Cognitive and academic outcomes in children with chronic kidney disease.

Authors:  Siah Kim; Anita Van Zwieten; Jennifer Lorenzo; Rabia Khalid; Suncica Lah; Kerry Chen; Madeleine Didsbury; Anna Francis; Steven Mctaggart; Amanda Walker; Fiona E Mackie; Chanel Prestidge; Armando Teixeira-Pinto; Allison Tong; Katrina Blazek; Belinda Barton; Jonathan C Craig; Germaine Wong
Journal:  Pediatr Nephrol       Date:  2022-03-03       Impact factor: 3.651

5.  Safeguarding children and young people requiring kidney replacement therapy: challenges and potential opportunities.

Authors:  Hannah Jacob; Matko Marlais
Journal:  Pediatr Nephrol       Date:  2021-07-10       Impact factor: 3.714

6.  Brain abnormalities in children and adolescents with chronic kidney disease.

Authors:  Mina Matsuda-Abedini; Kevin Fitzpatrick; Waverly R Harrell; Debbie S Gipson; Stephen R Hooper; Aysenil Belger; Ken Poskitt; Steven P Miller; Bruce H Bjornson
Journal:  Pediatr Res       Date:  2018-07-02       Impact factor: 3.756

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.